Blue Trust’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Blue Trust's IBRX Position: Q3 2026 in Review
Blue Trust sold out of ImmunityBio (IBRX) in Q3 2026, closing a stake of 668 shares — an estimated $5.85K sold.
Blue Trust first reported a position in IBRX in Q1 2026 and held it in 2 quarters. The position peaked at $5.92K in Q1 2026. 321 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Blue Trust reported no remaining ImmunityBio position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 668 ImmunityBio shares in Q3 2026, an estimated $5.85K.
- Blue Trust first reported a position in ImmunityBio in Q1 2026 and held it in 2 quarters.
- Blue Trust's ImmunityBio position peaked at $5.92K in Q1 2026.
- 321 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.